ClinVar Miner

Submissions for variant NM_017875.4(SLC25A38):c.625G>C (p.Asp209His) (rs146864395)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000778698 SCV000915051 likely pathogenic Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive 2018-08-13 criteria provided, single submitter clinical testing The SLC25A38 c.625G>C (p.Asp209His) missense variant has been reported in at least two studies in which it is found in a compound heterozygous state in a total of four unrelated individuals diagnosed with congenital sideroblastic anemia, where pyridoxine-refractory status was not specified (Guernsey et al. 2009; Kannengiesser et al. 2011). Three of the four second variants were null, with the fourth being a missense change. The variant was also been found in heterozygous state in the unaffected parents of at least one of the individuals. The p.Asp209His variant was absent from 286 control individuals and is reported at a frequency of 0.000045 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence, the p.Asp209His variant is classified as likely pathogenic for pyridoxine-refractory sideroblastic anemia.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.